C12N 2740/14051
Methods of production or purification of viral material
C12N2740/14051 (Methods of production or purification of viral material) appears on 9 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 4
- Assignees
- 7
- Inventors
- 18
- Latest grant
- 31 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Soluble and immunoreactive variants of HTLV capsid antigen P2431 Jan 2023US 11,567,079 B2Roche Diagnostics Operations, Inc.
- Chimeric peptides against HTLV-122 Sep 2020US 10,780,159 B2
- Soluble and immunoreactive variants of HTLV capsid antigen p245 Nov 2019US 10,466,242 B2Roche Diagnostics Operations, Inc.
- Method for producing an adapted virus population from an African green monkey kidney cell line12 Sep 2000US 6,117,667 ADyncorp
- Method for producing a virus from an african green monkey kidney cell line15 Feb 2000US 6,025,182 ADyncorp
- Dual targeted gene therapy17 Sep 2026US 2026/0275377 A1Kelonia Therapeutics, Inc.
- Soluble and immunoreactive variants of htlv capsid antigen p2430 Jan 2020US 2020/0033342 A1Roche Diagnostics Operations, Inc.
- Chimeric peptides against htlv-112 Apr 2018US 2018/0099042 A1
- Soluble and immunoreactive variants of htlv capsid antigen p2429 Jun 2017US 2017/0184591 A1Roche Diagnostics Operations, Inc.
Most cited
By later US patents
- Process for preparing virus disease live vaccines107US 4,071,618 AThe Research Foundation for Microbial Diseases of Osaka University · 1978
- Method of producing a virus vaccine from an African green monkey kidney cell line4US 5,911,998 ADyncorp · 1999
- Methods for propagating retrovirus for use in antibody assays2US 5,514,542 AGenetic Systems Corporation · 1996
- African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines1US 5,646,033 ADyncorp · 1997
- Method for producing a virus from an african green monkey kidney cell line1US 6,025,182 ADyncorp · 2000